Suzanne Jurriaans

7.7k total citations
128 papers, 5.6k citations indexed

About

Suzanne Jurriaans is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Suzanne Jurriaans has authored 128 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Virology, 96 papers in Infectious Diseases and 25 papers in Epidemiology. Recurrent topics in Suzanne Jurriaans's work include HIV Research and Treatment (103 papers), HIV/AIDS drug development and treatment (73 papers) and HIV/AIDS Research and Interventions (66 papers). Suzanne Jurriaans is often cited by papers focused on HIV Research and Treatment (103 papers), HIV/AIDS drug development and treatment (73 papers) and HIV/AIDS Research and Interventions (66 papers). Suzanne Jurriaans collaborates with scholars based in Netherlands, United States and United Kingdom. Suzanne Jurriaans's co-authors include Joep M. A. Lange, Jan M. Prins, Gerrit Jan Weverling, Ben Berkhout, Margreet Bakker, Hanneke Schuitemaker, Jaap Goudsmit, Ferdinand W N M Wit, Roel A. Coutinho and Bob van Gemen and has published in prestigious journals such as The Lancet, PLoS ONE and PEDIATRICS.

In The Last Decade

Suzanne Jurriaans

127 papers receiving 5.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Suzanne Jurriaans	3.7k	3.5k	1.7k	888	815	128	5.6k
Anna María Geretti	3.5k 0.9×	3.0k 0.9×	2.7k 1.6×	592 0.7×	1.4k 1.7×	195	5.9k
Andrea Kovács	2.4k 0.7×	1.7k 0.5×	1.8k 1.0×	593 0.7×	590 0.7×	133	4.4k
Jorge del Romero	2.2k 0.6×	1.5k 0.4×	1.6k 0.9×	397 0.4×	515 0.6×	144	3.7k
Brian K. Agan	2.2k 0.6×	1.7k 0.5×	1.6k 0.9×	485 0.5×	484 0.6×	167	4.6k
Marie‐Laure Chaix	4.9k 1.3×	4.5k 1.3×	2.1k 1.2×	708 0.8×	1.3k 1.6×	214	6.8k
Lisa M. Frenkel	3.6k 1.0×	2.8k 0.8×	2.1k 1.2×	584 0.7×	150 0.2×	193	5.4k
Françis Barin	3.1k 0.8×	3.6k 1.0×	2.0k 1.2×	1.5k 1.7×	829 1.0×	210	5.9k
William Borkowsky	2.8k 0.7×	3.8k 1.1×	2.3k 1.3×	2.6k 2.9×	249 0.3×	155	6.7k
Juan González‐Lahoz	2.6k 0.7×	1.7k 0.5×	2.3k 1.3×	391 0.4×	1.7k 2.1×	172	4.9k
Yvonne J. Bryson	2.8k 0.8×	2.7k 0.8×	2.8k 1.6×	1.5k 1.7×	184 0.2×	143	6.3k

Countries citing papers authored by Suzanne Jurriaans

Since Specialization

Citations

This map shows the geographic impact of Suzanne Jurriaans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Jurriaans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Jurriaans more than expected).

Fields of papers citing papers by Suzanne Jurriaans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Jurriaans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Jurriaans. The network helps show where Suzanne Jurriaans may publish in the future.

Co-authorship network of co-authors of Suzanne Jurriaans

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Jurriaans. A scholar is included among the top collaborators of Suzanne Jurriaans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Jurriaans. Suzanne Jurriaans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boyd, Anders, Alexander Pasternak, Irma Maurer, et al.. (2025). Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption. AIDS. 39(7). 812–816. 1 indexed citations

Boyd, Anders, Liza Coyer, Janke Schinkel, et al.. (2023). Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study. Vaccine. 41(12). 2035–2045. 4 indexed citations

Coyer, Liza, Anders Boyd, Janke Schinkel, et al.. (2022). SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020. BMJ Open. 12(1). e052752–e052752. 14 indexed citations

Hoornenborg, Elske, Maria Prins, Roel Achterbergh, et al.. (2017). Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report. The Lancet HIV. 4(11). e522–e528. 54 indexed citations

Borgdorff, Hanneke, Evgeni Tsivtsivadze, Rita Verhelst, et al.. (2014). Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. The ISME Journal. 8(9). 1781–1793. 203 indexed citations

Kuyl, Antoinette C. van der, Fokla Zorgdrager, Boris M. Hogema, et al.. (2013). High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011. BMC Infectious Diseases. 13(1). 540–540. 14 indexed citations

Gras, Luuk, Ronald B. Geskus, Suzanne Jurriaans, et al.. (2013). Has the Rate of CD4 Cell Count Decline before Initiation of Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic among MSM?. PLoS ONE. 8(5). e64437–e64437. 13 indexed citations

Kuyl, Antoinette C. van der, Margreet Bakker, Suzanne Jurriaans, et al.. (2013). Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013. Retrovirology. 10(1). 93–93. 11 indexed citations

Grijsen, Marlous L., Radjin Steingrover, Ferdinand W N M Wit, et al.. (2012). No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial. PLoS Medicine. 9(3). e1001196–e1001196. 65 indexed citations

10.

Kuyl, Antoinette C. van der, Suzanne Jurriaans, Nicole Back, et al.. (2010). Unusual Cluster of HIV Type 1 Dual Infections in Groningen, The Netherlands. AIDS Research and Human Retroviruses. 27(4). 429–433. 8 indexed citations

11.

Branger, Judith, Jan T. M. van der Meer, R J van Ketel, Suzanne Jurriaans, & Jan M. Prins. (2009). High Incidence of Asymptomatic Syphilis in HIV-Infected MSM Justifies Routine Screening. Sexually Transmitted Diseases. 36(2). 84–85. 74 indexed citations

12.

Dukers–Muijrers, Nicole H. T. M., H Fennema, Eric M. van der Snoek, et al.. (2007). HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984–2005. AIDS. 21(4). 491–499. 45 indexed citations

13.

Cornelissen, Marion, Nico Kloosterboer, Kristel M. L. Crommentuyn, et al.. (2007). Antiviral Activity of HIV Type 1 Protease Inhibitors Nelfinavir and Indinavir in Vivo Is Not Influenced by P-Glycoprotein Activity on CD4 ⁺ T Cells. AIDS Research and Human Retroviruses. 23(1). 19–27. 6 indexed citations

14.

Hoek, Lia van der, Georgios Pollakis, Vladimir V. Lukashov, et al.. (2007). Characterization of An HIV-1 Group M Variant That Is Distinct from The Known Subtypes. AIDS Research and Human Retroviruses. 23(3). 466–470. 10 indexed citations

15.

Prins, Jan M., Evelien M. Bunnik, C. Erik Hack, et al.. (2007). Intravenous Immunoglobulin (IVIG) Treatment for Modulation of Immune Activation in Human Immunodeficiency Virus Type 1 Infected Therapy-Naive Individuals. AIDS Research and Human Retroviruses. 23(11). 1348–1353. 8 indexed citations

16.

Weverling, Gerrit Jan, Monika Peeters, Aza Rakhmanova, et al.. (2003). TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen. AIDS. 17(18). 2623–2627. 33 indexed citations

17.

Notermans, Daan W., Frank de Wolf, Peter Oudshoorn, et al.. (2000). Evaluation of a Second-Generation Nucleic Acid Sequence-Based Amplification Assay for Quantification of HIV Type 1 RNA and the Use of Ultrasensitive Protocol Adaptations. AIDS Research and Human Retroviruses. 16(15). 1507–1517. 15 indexed citations

18.

Wit, Tobias F. Rinke de, Ermias Hailu, Tsehaynesh Messele, et al.. (1999). Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS. 13(3). 381–389. 61 indexed citations

19.

Gemen, Bob van, et al.. (1995). The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application.. Genome Research. 4(4). S177–S184. 33 indexed citations

20.

Jurriaans, Suzanne, John T. Dekker, & Anthony de Ronde. (1992). HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individuals. AIDS. 6(7). 635–642. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact